Elektron Technology
Follow Elektron Technology on Linkedin

Checkit -  Automated monitoring and work management software


We've just released the latest software for the MPS II macular pigment reader: Version 5. Watch this video to see it in action. Version 5 offers improvements including even better clarity of results and reporting, improved control over data management and usability enhancements.

Watch our new video for Checkit. The smart, wireless food safety monitoring system thet can save you time, eliminate paperwork and safeguard your business.

Enter John Wilson, the globetrotting chief executive of Elektron Technology, based on the edge of the city at the Broers Building, off Madingley Road on Cambridge University’s West Site.

We often make a big play out of the fact that our Bulgin Buccaneer connectors work in hostile environments – including underwater.

Cambridge UK technology devised to eliminate the threat of food poisoning is being trialled at the Yankee Stadium baseball venue in New York and in Los Angeles restaurants.

Optometry Today was given the chance to try out macular pigment screening device MPS II at Optrafair 2013 – and discover the benefits to optometrists and their patients.

By promoting the importance of early detection and treatment, as well as the use of proper eye safety practices, throughout May each year the NEI aims to prevent help vision loss and blindness nationally.

Elektron Technology brings new, fast-moving engineered products to the market on a global scale.

Winner announced! Who won the thrilling supercar experience courtesy of Elektron Technology and Topcon at Optrafair 2013?

Over 300 optometrists tested the new portable MPS II macular pigment scanner on the Topcon stand at Optrafair 2013. The event comes ahead of the announcement of the AREDS 2 trial next month which is widely expected to produce more evidence for the importance of screening macular pigment in patients at risk of age-related macular degeneration (AMD).

Taking place at Downing College, Cambridge University on 10-13 July 2013, the event will explore up-to-date hypotheses and the supporting research data into the role of the macular carotenoids in age-related macular degeneration (AMD), vision, and cognitive function.